Latest Breaking News On - Lane caputo compensation - Page 1 : comparemela.com

Standard Lithium : MESSAGE FROM OUR CEO - Form 6-K

MESSAGE FROM OUR CEO Dear Valued Shareholders: The past year has presented the lithium sector with significant challenges, from market specific headwinds to.

United statesNew yorkUnited kingdomMoss lakeBritish columbiaVolker berlKara normanAnca rusuClaudia dorazioAndy robinsonAnthony alvaroSteve rossAndrew robinsonJason tielkerRobert crossRobert mintak

NOTICE OF ANNUAL GENERALAND SPECIAL MEETING OFSHAREHOLDERSANDMANAGEMENT INFORMATIONCIRCULARMeeting Date: Thursday, June 20, 2024 - Form 6-K

NOTICE OF ANNUAL GENERALAND SPECIAL MEETING OFSHAREHOLDERSANDMANAGEMENT INFORMATIONCIRCULARMeeting Date: Thursday, June 20, 2024 - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSouth africaFree stateComunidad autonoma de catalunaProvince of british columbiaBritish columbiaWestern capeLaurel hillNew south walesGold fieldsMasbate cityCity ofUnited kingdomUniversity of chicagoFrance general

Greenfire Resources : Management INFORMATION CIRCULAR DATED April 2, 2024 - Form 6-K

management INFORMATION CIRCULAR DATED April 2, 2024 WHO WE ARE what s inside .

Richmond hillCity ofUnited kingdomNew yorkUnited statesRocky mountainsCanada generalZuid hollandW derek aylesworthVenkat sivaKevin millarGoldman sachMatt perkalTony kraljicJonathan kleschAlbert ma

Standard Lithium : Form 51-102F6 - Statement of Executive Compensation - Form 6-K -November 17, 2023 at 05:03 pm EST

Form 51-102F6 STATEMENT OF EXECUTIVE COMPENSATION The following information is presented in accordance with Form 51-102F6 - Statement of Executive Compensation.

United statesStephen rossVolker berlAndrew robinsonClaudia dorazioRobert crossAnca rusuJason tielkerSteve rossKara normanRobert mintakAndy robinsonAnthony alvaroNational instrumentDirectors of the companyEquity research pharmaceuticals for deutsche bank